Silk constructs for delivery of musculoskeletal therapeutics

被引:96
作者
Meinel, Lorenz [1 ]
Kaplan, David L. [2 ]
机构
[1] Univ Wurzburg, Inst Pharm & Food Chem, DE-97074 Wurzburg, Germany
[2] Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA
关键词
Silk-fibroin; Musculoskeletal diseases; Drug delivery; Implant; Injectable drug delivery systems; GROWTH-FACTOR-I; MESENCHYMAL STEM-CELLS; PLURONIC BLOCK-COPOLYMERS; BONE-MINERAL DENSITY; CONTROLLED-RELEASE; LONG-TERM; FIBROIN SCAFFOLDS; THERMOREVERSIBLE GELATION; SITU PHOTOPOLYMERIZATION; MECHANICAL-PROPERTIES;
D O I
10.1016/j.addr.2012.03.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Silk fibroin (SF) is a biopolymer with distinguishing features from many other bio-as well as synthetic polymers. From a biomechanical and drug delivery perspective, SF combines remarkable versatility for scaffolding (solid implants, hydrogels, threads, solutions), with advanced mechanical properties and good stabilization and controlled delivery of entrapped protein and small molecule drugs, respectively. It is this combination of mechanical and pharmaceutical features which renders SF so exciting for biomedical applications. This pattern along with the versatility of this biopolymer has been translated into progress for musculoskeletal applications. We review the use and potential of silk fibroin for systemic and localized delivery of therapeutics in diseases affecting the musculoskeletal system. We also present future directions for this biopolymer as well as the necessary research and development steps for their achievement. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1111 / 1122
页数:12
相关论文
共 208 条
[1]   Silk fibroin protein from mulberry and non-mulberry silkworms: cytotoxicity, biocompatibility and kinetics of L929 murine fibroblast adhesion [J].
Acharya, Chitrangada ;
Ghosh, Sudip K. ;
Kundu, S. C. .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2008, 19 (08) :2827-2836
[2]   The effect of lactose-conjugated silk biomaterials on the development of fibrogenic fibroblasts [J].
Acharya, Chitrangada ;
Hinz, Boris ;
Kundu, Subhas C. .
BIOMATERIALS, 2008, 29 (35) :4665-4675
[3]   Silk-based biomaterials [J].
Altman, GH ;
Diaz, F ;
Jakuba, C ;
Calabro, T ;
Horan, RL ;
Chen, JS ;
Lu, H ;
Richmond, J ;
Kaplan, DL .
BIOMATERIALS, 2003, 24 (03) :401-416
[4]   Silk matrix for tissue engineered anterior cruciate ligaments [J].
Altman, GH ;
Horan, RL ;
Lu, HH ;
Moreau, J ;
Martin, I ;
Richmond, JC ;
Kaplan, DL .
BIOMATERIALS, 2002, 23 (20) :4131-4141
[5]   Parathyroid Hormone PTH(1-34) Formulation that Enables Uniform Coating on a Novel Transdermal Microprojection Delivery System [J].
Ameri, Mahmoud ;
Fan, Shelley C. ;
Maa, Yuh-Fun .
PHARMACEUTICAL RESEARCH, 2010, 27 (02) :303-313
[6]   Biodegradation of Bombyx mori silk fibroin fibers and films [J].
Arai, T ;
Freddi, G ;
Innocenti, R ;
Tsukada, M .
JOURNAL OF APPLIED POLYMER SCIENCE, 2004, 91 (04) :2383-2390
[7]   Factors affecting short-term and long-term stabilities of proteins (Reprinted from Advanced Drug Delivery Reviews, vol 9, pg 201-237, 1992) [J].
Arakawa, T ;
Prestrelski, SJ ;
Kenney, WC ;
Carpenter, JF .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :307-326
[8]   PROTEIN-SOLVENT INTERACTIONS IN PHARMACEUTICAL FORMULATIONS [J].
ARAKAWA, T ;
KITA, Y ;
CARPENTER, JF .
PHARMACEUTICAL RESEARCH, 1991, 8 (03) :285-291
[9]   Micro-scale devices for transdermal drug delivery [J].
Arora, Anubhav ;
Prausnitz, Mark R. ;
Mitragotri, Samir .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (02) :227-236
[10]   Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors [J].
Augst, Alexander ;
Marolt, Darja ;
Freed, Lisa E. ;
Vepari, Charu ;
Meinel, Lorenz ;
Farley, Michelle ;
Fajardo, Robert ;
Patel, Nipun ;
Gray, Martha ;
Kaplan, David L. ;
Vunjak-Novakovic, Gordana .
JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2008, 5 (25) :929-939